ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Teoh, K. H.
Right arrow Articles by Reilly, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Teoh, K. H.
Right arrow Articles by Reilly, P.

The Annals of Thoracic Surgery, Vol 44, 40-47, Copyright © 1987 by The Society of Thoracic Surgeons


ARTICLES

Blood conservation with membrane oxygenators and dipyridamole

KH Teoh, GT Christakis, RD Weisel, MM Madonik, J Ivanov, PY Wong, AV Mee, D Levitt, A Benak and P Reilly

Cardiopulmonary bypass induces platelet activation and dysfunction, which result in platelet deposition and depletion. Reduced platelet numbers and abnormal platelet function may contribute to postoperative bleeding. A membrane oxygenator may preserve platelets and reduce bleeding more than a bubble oxygenator, and the antiplatelet agent dipyridamole may protect platelets intraoperatively and reduce bleeding postoperatively. A prospective randomized trial was performed in 44 patients undergoing elective coronary artery bypass grafting to assess the effects of the membrane oxygenator and dipyridamole on platelet counts, platelet activation products, and postoperative bleeding. Patients who were randomized to receive a bubble oxygenator and no dipyridamole had the lowest postoperative platelet counts, the greatest blood loss, and the most blood products transfused. Platelet counts were highest and blood loss was least in patients randomized to receive a membrane oxygenator and dipyridamole (p less than .05). A bubble oxygenator with dipyridamole and a membrane oxygenator without dipyridamole resulted in intermediate postoperative platelet counts and blood loss. Arterial thromboxane B2 and platelet factor 4 concentrations were elevated on cardiopulmonary bypass in all groups. Both the membrane oxygenator and dipyridamole were independently effective (by multivariate analysis) in preserving platelets. Optimal blood conservation was achieved with a membrane oxygenator and dipyridamole.


This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
G. J. Despotis, M. S. Avidan, and C. W. Hogue Jr
Mechanisms and attenuation of hemostatic activation during extracorporeal circulation
Ann. Thorac. Surg., November 1, 2001; 72(5): S1821 - 1831.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
A. Weerasinghe and K. M. Taylor
The platelet in cardiopulmonary bypass
Ann. Thorac. Surg., December 1, 1998; 66(6): 2145 - 2152.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
R. G. H. Speekenbrink, A. B. A. Vonk, C. R. H. Wildevuur, and L. Eijsman
Hemostatic Efficacy of Dipyridamole, Tranexamic Acid, and Aprotinin in Coronary Bypass Grafting
Ann. Thorac. Surg., February 1, 1995; 59(2): 438 - 442.
[Abstract] [Full Text]


Home page
BMJHome page
Antiplatelet Trialists
Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients
BMJ, January 8, 1994; 308(6921): 81 - 106.
[Abstract] [Full Text]


Home page
PerfusionHome page
Z. A Varga
Autologous plateletpheresis in cardiac surgery
Perfusion, November 1, 1993; 8(6): 471 - 476.
[Abstract] [PDF]


Home page
PerfusionHome page
R. D Weisel
Agents that modify haemostasis after cardiopulmonary bypass
Perfusion, May 1, 1993; 8(1_suppl): 6 - 12.
[Abstract] [PDF]


Home page
PerfusionHome page
D. M Cosgrove
Use of aprotinin in repeat myocardial revascularization: Cleveland Clinic experience
Perfusion, May 1, 1993; 8(1_suppl): 36 - 42.
[Abstract] [PDF]


Home page
PerfusionHome page
D. Tixier, D. Loisance, P. Deleuze, M. Hillion, H. Jouault, G. Bajan, and J. Cachera
Blood saving in cardiac surgery: simple approach and tendencies
Perfusion, October 1, 1991; 6(4): 265 - 273.
[PDF]


Home page
PerfusionHome page
J. Driessen, G. Fransen, L. Rondelez, E. Schelstraete, and L. Gevaert
Comparison of the standard roller pump and a pulsatile centrifugal pump for extracorporeal circulation during routine coronary artery bypass grafting
Perfusion, October 1, 1991; 6(4): 303 - 311.
[Abstract] [PDF]


Home page
PerfusionHome page
M. Sellman, T. Ivert, M. Blomback, and B. Semb
Haematological effects of a depth absorption arterial line filter during extracorporeal circulation
Perfusion, October 1, 1989; 4(4): 255 - 264.
[Abstract] [PDF]


Home page
PerfusionHome page
B. P Bidstrup
Review article : Blood conservation in cardiac surgery: can drugs help?
Perfusion, July 1, 1988; 3(3): 171 - 177.
[PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1987 by The Society of Thoracic Surgeons.